All Pharmaceuticals articles – Page 7
-
Article
Taro appoints accounting chief
Taro Pharmaceutical Industries announced the appointment of Daphne Huang as vice president, CFO and chief accounting officer.
-
Article
Tricida adds chief compliance officer
Pharmaceutical firm Tricida announced the hiring of Robert McKague as executive vice president, general counsel and chief compliance officer.
-
ArticleDOJ intervenes in whistleblower suit against Mallinckrodt
The Department of Justice has intervened in a whistleblower lawsuit against Mallinckrodt over allegations the drug maker knowingly underpaid Medicaid rebates it owed due to significant price increases to its drug Acthar.
-
Article
Trevena tabs chief legal and compliance officer
Biopharmaceutical company Trevena announced the appointment of Scott Applebaum as chief legal and compliance officer and senior vice president of regulatory affairs.
-
ArticlePractice Fusion to overhaul compliance after $145M kickback resolution
Practice Fusion will pay a total of $145 million to resolve criminal and civil investigations for its leading role in an opioid kickback scheme. Particularly notable are the new compliance obligations imposed upon it, which are as weighty and significant as the fine itself.
-
ArticleEurope’s high court strikes blow to drug companies in ‘pay-for-delay’ case
The U.K. Competition and Markets Authority won a victory in a decision by Europe’s high court, ruling GlaxosmithKline’s entering of a financial deal with industry rivals to delay the generic version of its drugs violates EU competition law.
-
Article
Eli Lilly adds general counsel
Pharmaceuticals firm Eli Lilly and Company announced Anat Hakim will join the company as senior vice-president and general counsel.
-
ArticleTeva to pay $54M in FCA whistleblower settlement
Teva Pharmaceuticals has reached a $54 million settlement in a lawsuit filed by two whistleblowers over allegations the drug company bribed physicians through numerous “sham” speaker programs in exchange for prescribing Teva drugs.
-
PremiumTop ethics and compliance failures of 2019
From antitrust and privacy concerns in the tech world to compliance officer liability in the pharmaceutical industry to unethical practices in the banking and accounting professions, more than a dozen companies made Compliance Week’s list of the biggest compliance fails in 2019.
-
ArticleICO hands out first GDPR fine as BA, Marriott cases linger
The U.K. Information Commissioner’s Office has levied its first fine under the GDPR against a London-based pharmacy. Record-setting penalties announced by the ICO in July against British Airways and Marriott are still not finalized.
-
ArticleAlleged compliance failures at Omnicare lead to healthcare fraud lawsuit
A series of alleged compliance failures at pharmaceutical services provider Omnicare has resulted in the Department of Justice intervening in yet another civil healthcare fraud lawsuit against the company.
-
Article
Signant Health appoints chief compliance officer
Pharmaceutical technology firm Signant Health announced the appointment of Paul Drake as chief compliance and security officer.
-
Article
Roche veteran general counsel to retire
Swiss pharmaceutical firm Roche announced Gottlieb Keller will retire as general counsel at the end of March 2020. Keller’s career at Roche spanned 35 years.
-
Article
BioPlus Specialty Pharmacy hires chief compliance and privacy officer
BioPlus Specialty Pharmacy has named Brian Cherico as its chief compliance and privacy officer.
-
ArticleFormer Herbalife execs charged with FCPA violations
The DOJ has charged two former executives of Herbalife with violations of the Foreign Corrupt Practices Act for bribing Chinese government officials for over a decade and then trying to cover up the illicit payments.
-
ArticleLabeling employee a ‘compliance risk’ not defamation, says court
A former Biomet Argentina employee—in a bit of FCPA hot water—landed on his company’s restricted persons list, sued for defamation, and lost.
-
Article
Aerie Pharmaceuticals appoints chief compliance officer
Aerie Pharmaceuticals has appointed Charlene Davis as vice president and chief compliance officer.
-
ArticleQ&A: Shaping culture for the greater good at AstraZeneca
In this one-on-one, we caught up with Louise Vamvoukaki, director of sustainability education and engagement at AstraZeneca, who shared how the company overhauled its organizational culture through design of its Code of Ethics.
-
ArticleAvanir to pay $116M for engaging in kickback scheme
Avanir Pharmaceuticals will pay a combined $116 million in civil and criminal penalties for paying kickbacks to a physician to induce prescriptions of its drug Nuedexta, the Department of Justice announced.
-
ArticleMylan finalizes $30M EpiPen settlement with SEC
Mylan has finalized a previously disclosed $30 million settlement with the SEC for alleged accounting and disclosure failures surrounding its popular EpiPen.